This article was previously published February 15, 2018, and has been updated with new information. Oftentimes the simplest strategies pay great dividends. Getting sensible sun exposure and grounding — walking barefoot on the ground, whether it’s sand, grass or rock — are two examples. Sleeping on an incline is another. While sleeping on a horizontal… Read More »
In a recent MedCram interview (above), Rhonda Patrick, Ph.D., cofounder of Found My Fitness, provided a wonderful summary of the benefits of sauna therapy, and some of the basic principles of sauna treatment. Further below, I’ve also included another excellent video featuring neuroscientist Dr. Andrew Huberman, in which he takes a deep dive into the… Read More »
A study from Malawi has found that short-term campaigns of HIV self-testing, whose design and implementation are led by community groups, can rapidly increase the uptake of HIV testing and antiretroviral therapy among underserved populations. Recently published in PLOS Medicine, the study also reported a lower cost for this intervention than for other testing programmes.… Read More »
If you are looking for gay therapists in NYC or in other parts of the country, then we highly recommend that you check out our recommendations because these gay therapists can help you without meeting in person with their online services. Some of these therapists have graduated from prestigious schools that are known to support… Read More »
A cost-effectiveness analysis has found that injectable, long-lasting antiretroviral therapy (ART) would need to cost no more than $ 131 a year in order to be cost-effective if used for patients who are not fully virally suppressed in lower-income settings in regions like sub-Saharan Africa. The analysis found that injectable cabotegravir/rilpivirine would only reach the… Read More »
FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with Relapsing Multiple Sclerosis Print this page Basel, August 20, 2020 — Novartis today announced that the US Food and Drug Administration (FDA) has approved Kesimpta® (ofatumumab, formerly OMB157) as an injection for subcutaneous use for the treatment of relapsing forms of multiple sclerosis (RMS), to include clinically… Read More »